Zebrafish Models for Human Diseases and Drug Discovery

Drug Efficacy, Safety, and Biologics Discovery: Emerging Technologies and Tools

Volumn , Issue , 2008, Pages 115-133

  Zhong, Hanbing ^a   Liu, Ning Ai ^b   Lin, Shuo ^a,c  

^a PEKING UNIVERSITY   (China)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Zebrafish models of human diseases; Zebrafish technologies; Zebrafish novel platform for drug discovery

Indexed keywords

EID: 84889775215     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470431818.ch5     Document Type: Chapter

References (93)

1. Hamilton F. An account of the fishes found in the river ganges and its branches. Edinburgh, 1822.
2. Shrestha J. Fishes of Nepal. Tribhuvan University, Kathmandu, 1981.
3. Westerfield M. The zebrafish book. University of Oregon Press, Eugene, Oregon, 2000.
4. Daga RR, Thode G, Amores A. Chromosome complement, C-banding, Ag-NOR and replication banding in the zebrafish Danio rerio. Chromosome Res 1996; 4: 29-32.
5. Hinegardner R, Rosen D. Cellular DNA content and the evolution of teleostean fishes. Am Nat 1972; 106: 621-44.
6. Laale HW. The biology and use of zebrafish, Brachydanio rerio in fisheries research-literature review. J Fish Biol 1977; 10: 121-173.
7. Streisinger G, Walker C, Dower N, Knauber D, Singer F. Production of clones of homozygous diploid zebra fish ( Brachydanio rerio ). Nature 1981; 291: 293-6.
8. Eisen JS. Zebrafish make a big splash. Cell 1996; 87: 969-77.
9. Driever W, Solnica-Krezel L, Schier AF, Neuhauss SC, Malicki J, Stemple DL, et al. A genetic screen for mutations affecting embryogenesis in zebrafish. Development 1996; 123: 37-46.
10. Haffter P, Granato M, Brand M, Mullins MC, Hammerschmidt M, Kane DA, et al. The identification of genes with unique and essential functions in the development of the zebrafish, Danio rerio. Development 1996; 123: 1-36.
11. Patton EE, Zon LI. The art and design of genetic screens: zebrafish. Nat Rev 2001; 2: 956-66.
12. Amsterdam A, Hopkins N. Mutagenesis strategies in zebrafish for identifying genes involved in development and disease. Trends Genet 2006; 22: 473-8.
13. Sivasubbu S, Balciunas D, Amsterdam A, E kker SC. Insertional mutagenesis strategies in zebrafish. Genome Biol 2007; 8 ( suppl 1 ):S9.
14. Grunwald DJ, Streisinger G. Induction of recessive lethal and specific locus mutations in the zebrafish with ethyl nitrosourea. Genet Res 1992; 59: 103-16.
15. Mullins MC, Hammerschmidt M, Haffter P, Nusslein-Volhard C. Large-scale mutagenesis in the zebrafish: in search of genes controlling development in a vertebrate. Curr Biol 1994; 4: 189-202.
16. Solnica-Krezel L, Schier AF, Driever W. Efficient recovery of ENU-induced mutations from the zebrafish germline. Genetics 1994; 136: 1401-20.
17. Jin SW, Herzog W, Santoro MM, Mitchell TS, Frantsve J, Jungblut B, et al. A transgene-assisted genetic screen identifies essential regulators of vascular development in vertebrate embryos. Dev Biol 2007; 307: 29-42.
18. McCallum CM, Comai L, Greene EA, Henikoff S. Targeting induced local lesions IN genomes (TILLING) for plant functional genomics. Plant Physiol 2000; 123: 439-42.
19. Stemple DL. TILLING-a high-throughput harvest for functional genomics. Nat Rev 2004; 5: 145-50.
20. Zhang J, Talbot WS, Schier AF. Positional cloning identifies zebrafish one-eyed pinhead as a permissive EGF-related ligand required during gastrulation. Cell 1998; 92: 241-51.
21. Geisler R, Rauch GJ, Geiger-Rudolph S, Albrecht A, van Bebber F, Berger A, et al. Large-scale mapping of mutations affecting zebrafish development. BMC Genom 2007; 8: 11.
22. Wienholds E, Schulte-Merker S, Walderich B, P lasterk RH. Target-selected inactivation of the zebrafish rag1 gene. Science 2002; 297: 99-102.
23. Wienholds E, Plasterk RH. Target-selected gene inactivation in zebrafish. Meth Cell Biol 2004; 77: 69-90.
24. Draper BW, McCallum CM, Stout JL, Slade AJ, Moens CB. A high-throughput method for identifying N-ethyl-N-nitrosourea (ENU)-induced point mutations in zebrafish. Meth Cell Biol 2004; 77: 91-112.
25. Lin S, Gaiano N, Culp P, Burns JC, Friedmann T, Yee JK, et al. Integration and germ-line transmission of a pseudotyped retroviral vector in zebrafish. Science 1994; 265: 666-9.
26. Gaiano N, Amsterdam A, Kawakami K, Allende M, Becker T, Hopkins N. Insertional mutagenesis and rapid cloning of essential genes in zebrafish. Nature 1996; 383: 829-32.
27. Amsterdam A, Burgess S, Golling G, Chen W, Sun Z, Townsend K, et al. A large-scale insertional mutagenesis screen in zebrafish. Genes Dev 1999; 13: 2713-24.
28. Amsterdam A, Nissen RM, Sun Z, Swindell EC, Farrington S, Hopkins N. Identification of 315 genes essential for early zebrafish development. Proc Nat Acad Sci USA 2004; 101: 12792-7.
29. Wang D, Jao LE, Zheng N, Dolan K, Ivey J, Zonies S, et al. Efficient genome -wide mutagenesis of zebrafish genes by retroviral insertions. Proc Nat Acad Sci USA 2007; 104: 12428-33.
30. Gall JG, Pardue ML. Formation and detection of RNA-DNA hybrid molecules in cytological preparations. Proc Nat Acad Sci USA 1969; 63: 378-83.
31. Jin L, Lloyd RV. In situ hybridization: methods and applications. J Clini Lab Anal 1997; 11: 2-9.
32. Krauss S, Johansen T, Korzh V, Moens U, Ericson JU, Fjose A. Zebrafish pax [zf-a]: a paired box-containing gene expressed in the neural tube. EMBO J 1991; 10: 3609-19.
33. Thisse C, Thisse B. High-resolution in situ hybridization to whole-mount zebrafish embryos. Nat Protocols 2008; 3: 59-69.
34. Summerton J, Weller D. Morpholino antisense oligomers: design, preparation, and properties. Antisense Nucleic Acid Drug Dev 1997; 7: 187-95.
35. Nasevicius A, Ekker SC. Effective targeted gene " knockdown " in zebrafish. Nat Genet 2000; 26: 216-20.
36. Huang HG, Vogel SS, Liu NG, Melton DA, Lin S. Analysis of pancreatic development in living transgenic zebrafish embryos. Mol Cell Endocrinol 2001; 177: 117-24.
37. Liu NA, Liu Q, Wawrowsky K, Yang Z, Lin S, Melmed S. Prolactin receptor signaling mediates the osmotic response of embryonic zebrafish lactotrophs. Mol Endocrinol 2006; 20: 871-80.
38. Gong Z, Korzh V. Fish development and genetics the zebrafish and medaka models. Hackensack, NJ: World Scientific, 2004.
39. Meng A, Tang H, Ong BA, Farrell MJ, Lin S. Promoter analysis in living zebrafish embryos identifies a cis-acting motif required for neuronal expression of GATA-2. Proc Nat Acad Sci USA 1997; 94: 6267-72.
40. Higashijima S, Hotta Y, Okamoto H. Visualization of cranial motor neurons in live transgenic zebrafish expressing green fluorescent protein under the control of the islet-1 promoter/enhancer. J Neurosci 2000; 20: 206-18.
41. Yang Z, Jiang H, Chachainasakul T, Gong S, Yang XW, Heintz N, et al. Modified bacterial artificial chromosomes for zebrafish transgenesis. Methods 2006; 39: 183-8.
42. Penberthy WT, Shafizadeh E, Lin S. The zebrafish as a model for human disease. Front Biosci 2002; 7 :D1439-53.
43. Shin JT, Fishman MC. From Zebrafish to human: modular medical models. Ann Rev Genomics Human Genet 2002; 3: 311-40.
44. Kari G, Rodeck U, Dicker AP. Zebrafish: an emerging model system for human disease and drug discovery. Clin Pharmacol Therapeut 2007; 82: 70-80.
45. Orkin SH, Zon LI. Genetics of erythropoiesis: Induced mutations in mice and zebrafish. Ann Rev Genet 1997; 31: 33-60.
46. Amatruda JF, Zon LI. Dissecting hematopoiesis and disease using the zebrafish. Dev Biol 1999; 216: 1-15.
47. Weinstein BM, Schier AF, Abdelilah S, Malicki J, Solnica-Krezel L, Stemple DL, et al. Hematopoietic mutations in the zebrafish. Development 1996; 123: 303-9.
48. Ransom DG, Haffter P, Odenthal J, Brownlie A, Vogelsang E, Kelsh RN, et al. Characterization of zebrafish mutants with defects in embryonic hematopoiesis. Development 1996; 123: 311-9.
49. Risau W. Mechanisms of angiogenesis. Nature 1997; 386: 671-4.
50. Carmeliet P. Angiogenesis in life, disease and medicine. Nature 2005; 438: 932-6.
51. Isogai S, Horiguchi M, Weinstein BM. The vascular anatomy of the developing zebrafish: an atlas of embryonic and early larval development. Dev Biol 2001; 230: 278-301.
52. Childs S, Chen JN, Garrity DM, Fishman MC. Patterning of angiogenesis in the zebrafish embryo. Development 2002; 129: 973-82.
53. Stainier DY, Weinstein BM, Detrich HW, 3rd, Zon LI, Fishman MC. Cloche, an early acting zebrafish gene, is required by both the endothelial and hematopoietic lineages. Development 1995; 121: 3141-50.
54. Cross LM, Cook MA, Lin S, Chen JN, Rubinstein AL. Rapid analysis of angiogenesis drugs in a live fluorescent zebrafish assay. Arterioscler Thromb Vasc Biol 2003; 23: 911-2.
55. Zhong TP, Rosenberg M, Mohideen MA, Weinstein B, Fishman MC. gridlock, An HLH gene required for assembly of the aorta in zebrafish. Science 2000; 287: 1820-4.
56. Spagnoli FM. From endoderm to pancreas: a multistep journey. Cell Mol Life Sci 2007; 64: 2378-90.
57. Zorn AM, Wells JM. Molecular basis of vertebrate endoderm development. In: International review of cytology. Academic Press, 2007, p. 49-111.
58. Song J, Kim HJ, Gong Z, Liu N-A, Lin S. Vhnf1 acts downstream of Bmp, Fgf, and RA signals to regulate endocrine beta cell development in zebrafish. Dev Biol 2007; 303: 561-75.
59. Sun ZX, Hopkins N. Vhnf1, the MODY5 and familial GCKD-associated gene, regulates regional specification of the zebrafish gut, pronephros, and hindbrain. Genes Dev 2001; 15: 3217-29.
60. Sellick GS, Barker KT, Stolte-Dijkstra I, Fleischmann C, Coleman RJ, Garrett C, et al. Mutations in PTF1A cause pancreatic and cerebellar agenesis. Nat Genet 2004; 36: 1301-5.
61. Krapp A, Knofler M, Ledermann B, Burki K, Berney C, Zoerkler N, et al. The bHLH protein PTF1-p48 is essential for the formation of the exocrine and the correct spatial organization of the endocrine pancreas. Genes Dev 1998; 12: 3752-63.
62. Lin JW, Biankin AV, Horb ME, Ghosh B, Prasad NB, Yee NS, et al. Differential requirement for ptf1a in endocrine and exocrine lineages of developing zebrafish pancreas. Dev Biol 2004; 270: 474-86.
63. Lieschke GJ, Currie PD. Animal models of human disease: zebrafish swim into view. Nat Rev 2007; 8: 353-67.
64. Goessling W, North TE, Zon LI. New waves of discovery: modeling cancer in zebrafish. J Clin Oncol 2007; 25: 2473-9.
65. Stanton MF. Diethylnitrosamine-Induced hepatic degeneration and neoplasia in the aquarium fish, Brachydanio Rerio. J Nat Cancer Inst 1965; 34: 117-30.
66. Beckwith LG, Moore JL, Tsao-Wu GS, Harshbarger JC, Cheng KC. Ethylnitrosourea induces neoplasia in zebrafish ( Danio rerio ). Lab Invest J Tech Meth Pathol 2000; 80: 379-85.
67. Lam SH, Wu YL, Vega VB, Miller LD, Spitsbergen J, Tong Y, et al. Conservation of gene expression signatures between zebrafish and human liver tumors and tumor progression. Nat Biotechnol 2006; 24: 73-5.
68. Spitsbergen JM, Tsai HW, Reddy A, Miller T, Arbogast D, Hendricks JD, et al. Neoplasia in zebrafish ( Danio rerio ) treated with N-methyl-N ′-nitro-N -nitrosoguanidine by three exposure routes at different developmental stages. Toxicol Pathol 2000; 28: 716-25.
69. Spitsbergen JM, Tsai HW, Reddy A, Miller T, Arbogast D, Hendricks JD, et al. Neoplasia in zebrafish ( Danio rerio ) treated with 7,12-dimethylbenz[a]anthracene by two exposure routes at different developmental stages. Toxicol Pathol 2000; 28: 705-15.
70. Beroud C, Soussi T. The UMD-p53 database: new mutations and analysis tools. Human Mutat 2003; 21: 176-81.
71. Berghmans S, Murphey RD, Wienholds E, Neuberg D, Kutok JL, Fletcher CD, et al. tp53 mutant zebrafish develop malignant peripheral nerve sheath tumors. Proc Nat Acad Sci USA 2005; 102: 407-12.
72. Logan CY, Nusse R. The Wnt signaling pathway in development and disease. Ann Rev Cell Dev Biol 2004; 20: 781-810.
73. Hurlstone AF, Haramis AP, Wienholds E, Begthel H, Korving J, Van Eeden F, et al. The Wnt/beta-catenin pathway regulates cardiac valve formation. Nature 2003; 425: 633-7.
74. Haramis AP, Hurlstone A, van der Velden Y, Begthel H, Van den Born M, Offerhaus GJ, et al. Adenomatous polyposis coli-deficient zebrafish are susceptible to digestive tract neoplasia. EMBO Rep 2006; 7: 444-9.
75. Eisinger AL, Nadauld LD, Shelton DN, Peterson PW, Phelps RA, Chidester S, et al. The adenomatous polyposis coli tumor suppressor gene regulates expression of cyclooxygenase-2 by a mechanism that involves retinoic acid. J Biol Chem 2006; 281: 20474-82.
76. Shelton DN, Sandoval IT, Eisinger A, Chidester S, Ratnayake A, Ireland CM, et al. Up-regulation of CYP26A1 in adenomatous polyposis coli-deficient vertebrates via a WNT-dependent mechanism: implications for intestinal cell differentiation and colon tumor development. Cancer Res 2006; 66: 7571-7.
77. Langenau DM, Traver D, Ferrando AA, Kutok JL, Aster JC, Kanki JP, et al. Myc-induced T cell leukemia in transgenic zebrafish. Science 2003; 299: 887-90.
78. Langenau DM, Feng H, Berghmans S, Kanki JP, Kutok JL, Look AT. Cre/lox -regulated transgenic zebrafish model with conditional myc-induced T cell acute lymphoblastic leukemia. Proc Nat Acad Sci USA 2005; 102: 6068-73.
79. Onnebo SM, Condron MM, McPhee DO, Lieschke GJ, Ward AC. Hematopoietic perturbation in zebrafish expressing a tel-jak2a fusion. Exp Hematol 2005; 33: 182-8.
80. Sabaawy HE, Azuma M, Embree LJ, Tsai HJ, Starost MF, Hickstein DD. TEL -AML1 transgenic zebrafish model of precursor B cell acute lymphoblastic leukemia. Proc Nat Acad Sci USA 2006; 103: 15166-71.
81. Patton EE, Widlund HR, Kutok JL, Kopani KR, Amatruda JF, Murphey RD, et al. BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma. Curr Biol 2005; 15: 249-54.
82. Luderitz B. Cardiac glycosides: William Withering (1741-1799). J Interv Card Electrophysiol 2005; 14: 61-2.
83. Mueller RL, Scheidt S. History of drugs for thrombotic disease: discovery, development, and directions for the future. Circulation 1994; 89: 432-49.
84. MacRae CA, Peterson RT. Zebrafish-based small molecule discovery. Chem Biol 2003; 10: 901-8.
85. Sams-Dodd F. Target-based drug discovery: is something wrong? Drug Discov Today 2005; 10: 139-47.
86. Milan DJ, Peterson TA, Ruskin JN, Peterson RT, MacRae CA. Drugs that induce repolarization abnormalities cause bradycardia in zebrafish. Circulation 2003; 107: 1355-8.
87. Chan J, Bayliss PE, Wood JM, Roberts TM. Dissection of angiogenic signaling in zebrafish using a chemical genetic approach. Cancer Cell 2002; 1: 257-67.
88. Langheinrich U. Zebrafish: a new model on the pharmaceutical catwalk. Bioessays 2003; 25: 904-12.
89. King RW. Chemistry or biology: which comes first after the genome is sequenced? Chem Biol 1999; 6 :R327-33.
90. Wu X, Zhong H, Song J, Damoiseaux R, Yang Z, Lin S. Mycophenolic acid is a potent inhibitor of angiogenesis. Arterioscler Thromb Vasc Biol 2006; 26: 2414-6.
91. Huang Y, Liu Z, Huang H, Liu H, Li L. Effects of mycophenolic acid on endothelial cells. Int Immunopharmacol 2005; 5: 1029-39.
92. Chong CR, Qian DZ, Pan F, Wei Y, Pili R, Sullivan DJ, Jr, et al. Identification of type 1 inosine monophosphate dehydrogenase as an antiangiogenic drug target. J Med Chem 2006; 49: 2677-80.
93. Yu PB, Hong CC, Sachidanandan C, Babitt JL, Deng DY, Hoyng SA, et al. Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism. Nat Chem Biol 2008; 4: 33-41.